The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFB signaling pathway and nitric oxide induction in macrophages

Journal of Inflammation

Volumn 7, Issue , 2010, Pages

  Brodsky, Miri ^a   Halpert, Gilad ^a   Albeck, Michael ^a   Sredni, Benjamin ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE; DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTEIN P50;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; MACROPHAGE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 77149129263     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-7-3     Document Type: Article

References (28)

1. Nitric oxide and macrophage function. J MacMicking QW Xie C Nathan, Ann Rev Immuno 1997 15 323 50 10.1146/annurev.immunol.15.1.323 (Pubitemid 27169284)
2. Regulation of the expression of inducible nitric oxide synthase. H Kleinert A Pautz K Linker PM Schwarz, Eur J Pharmacol 2004 500 255 66 10.1016/j.ejphar.2004.07.030 15464038
3. Interleukin-6: an overview. J Van Snick, Ann Rev Immunol 1990 8 253 78 10.1146/annurev.iy.08.040190.001345
4. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. M Lappas M Permezel HM Georgiou GE Rice, Biol Reprod 2002 67 668 73 10.1095/biolreprod67.2.668 12135912
5. Molecular biology of cytokines. U Dendorfer, Artificial Organs 1996 20 437 44 10.1111/j.1525-1594.1996.tb04529.x 8725624
6. Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies. F D'Acquisto MJ May S Ghosh, Mol Interv 2002 2 22 35 10.1124/mi.2.1.22 14993359
7. NF-kappaB: a key role in inflammatory diseases. PP Tak GS Firestein, J Clin Invest 2001 107 7 11 10.1172/JCI11830 11134171
8. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. MH Pan SY Lin-Shiau JK Lin, Biochem Pharmacol 2000 60 1665 76 10.1016/S0006-2952(00)00489-5 11077049
9. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Y Kabe K Ando S Hirao M Yoshida H Handa, Antioxid Redox Signal 2005 7 395 403 10.1089/ars.2005.7.395 15706086
10. The NF-kappaB pathway. PN Moynagh, J Cell Sci 2005 118 4589 92 10.1242/jcs.02579 16219681
11. A new immunomodulating compound (AS-101) with potential therapeutic application. B Sredni RR Caspi A Klein Y Kalechman Y Danziger M Ben Ya'akov, et al. Nature 1987 330 173 176 10.1038/330173a0 3118216
12. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression. B Sredni R Gal IJ Cohen JE Dazard D Givol U Gafter, et al. FASEB J 2004 18 400 402 14656992
13. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. B Sredni RH Xu M Albeck U Gafter R Gal A Shani, et al. Int J Cancer 1996 65 97 103 10.1002/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F 8543404
14. Tellurium compounds: Selective inhibition of cysteine proteases and model reaction with thiols. A Albeck H Weitman B Sredni M Albeck, Inorganic Chemistry 1998 37 1704 1712 10.1021/ic971456t
15. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme. M Brodsky S Yosef R Galit M Albeck DL Longo A Albeck, et al. J Interferon Cytokine Res 2007 27 453 462 10.1089/jir.2007.0168 17572009
16. Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models. B Sredni R Geffen-Aricha W Duan M Albeck F Shalit HM Lander, et al. FASEB J 2007 21 1870 1883 10.1096/fj.06-7500com 17314138
17. Methods of Organic Chemistry in Organotellurium Compounds. KJ Irgolic, Georg Thieme Verlag Stuttgart. Vol. E12b of (Houben-Weyl) Additional and Supplementary Volumes of the 4th edition, Klamann D, 1990
18. Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injury. M Brodsky S Hirsh M Albeck B Sredni, J Hepatology 2009 51 3 491 503 10.1016/j.jhep.2009.04.024
19. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. RB Lorsbach WJ Murphy CJ Lowenstein SH Snyder SW Russell, J Biol Chem 1993 268 1908 1913 7678412
20. Introduction to NF-kappaB: players, pathways, perspectives. TD Gilmore, Oncogene 2006 25 6680 4 10.1038/sj.onc.1209954 17072321
21. Inflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo, in vitro, and in silico studies. Y Vodovotz PK Kim EZ Bagci GB Ermentrout CC Chow I Bahar, et al. Curr Mol Med 2004 4 753 62 10.2174/1566524043359944 15579022
22. Nitric oxide and the vascular endothelium. S Moncada EA Higgs, Handb Exp Pharmacol 2006 213 54 16999221
23. Cytokines as endogenous pyrogens. CA Dinarello, J Infect Dis 1999 179 Suppl 2 294 304 10.1086/513856 10081499
24. Regulation of the expression of inducible nitric oxide synthase. H Kleinert PM Schwarz U Forstermann, Biol Chem 2003 384 1343 64 10.1515/BC.2003.152 14669979
25. The organotellurium compound ammonium trichloro(dioxoethylene-o,o') tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice. E Okun Y Dikshtein A Carmely H Saida G Frei BA Sela, et al. FEBS J 2007 274 3159 3170 10.1111/j.1742-4658. 2007.05842.x 17521335
26. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. F Mercurio H Zhu BW Murray A Shevchenko BL Bennett J Li, et al. Science 1997 278 860 6 10.1126/science.278.5339.860 9346484
27. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. JR Matthews N Wakasugi JL Virelizier J Yodoi RT Hay, Nucleic Acids Res 1992 20 3821 30 10.1093/nar/20.15.3821 1508666
28. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. K Mitomo K Nakayama K Fujimoto X Sun S Seki K Yamamoto, Gene 1994 145 197 203 10.1016/0378-1119(94)90005-1 8056331